Form 4 Tracker
Michael J. Farrell

Director; Director, Chairman and CEO · 15 filings · Latest: Oct 7, 2026

RESMED INC
ZIMMER BIOMET HOLDINGS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RMD
Michael J. FarrellDirector, Chairman and CEOOct 7, 2026
Sale
$226.334,991$1.1M479,803
RMD
Michael J. FarrellDirector, Chairman and CEOOct 7, 2026
Option Exercise
$146.344,991$730.4K484,794
RMD
Farrell Michael J.—Oct 7, 2026
Proposed Sale
$226.334,991$1.1M—
RMD
Michael J. FarrellDirector, Chairman and CEOSep 8, 2026
Sale
$222.444,991$1.1M466,256
RMD
Michael J. FarrellDirector, Chairman and CEOSep 8, 2026
Option Exercise
$146.344,991$730.4K471,247
RMD
Farrell Michael J.—Sep 8, 2026
Proposed Sale
$226.224,991$1.1M—
RMD
Michael J. FarrellDirector, Chairman and CEOAug 7, 2026
Sale
$205.694,991$1.0M466,256
RMD
Michael J. FarrellDirector, Chairman and CEOAug 7, 2026
Option Exercise
$146.344,991$730.4K471,247
RMD
Farrell Michael J.—Aug 7, 2026
Proposed Sale
$205.694,991$1.0M—
RMD
Michael J. FarrellDirector, Chairman and CEOJul 7, 2026
Sale
$218.554,991$1.1M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOJul 7, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.—Jul 7, 2026
Proposed Sale
$219.344,991$1.1M—
RMD
Michael J. FarrellDirector, Chairman and CEOJun 8, 2026
Sale
$193.964,991$968.1K466,256
RMD
Michael J. FarrellDirector, Chairman and CEOJun 8, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.—Jun 8, 2026
Proposed Sale
$194.004,991$968.3K—
RMD
Michael J. FarrellDirector, Chairman and CEOMay 7, 2026
Sale
$207.824,991$1.0M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOMay 7, 2026
Option Exercise
$146.344,991$730.4K471,214
RMD
Farrell Michael J.—May 7, 2026
Proposed Sale
$207.824,991$1.0M—
RMD
Michael J. FarrellDirector, Chairman and CEOApr 7, 2026
Sale
$225.504,991$1.1M466,223
RMD
Michael J. FarrellDirector, Chairman and CEOApr 7, 2026
Option Exercise
$146.344,991$730.4K471,214

Page 1 of 3

Next →